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Abstract Calpain, a Ca2+-dependent cytosolic cysteine pro-
tease, proteolytically modulates specific substrates involved in
Ca2+-mediated intracellular events, such as signal transduction,
cell cycle, differentiation, and apoptosis. The 3D structure of m-
calpain, in the absence of Ca2+, revealed that the two subdomains
(domains IIa and IIb) of the protease domain (II) have an ‘open’
conformation, probably due to interactions with other domains.
Although the presence of an EF-hand structure was once
predicted in the protease domain, no explicit Ca2+-binding
structure was identified in the 3D structure. Therefore, it is
predicted that if the protease domain is excised from the calpain
molecule, it will have a Ca2+-independent protease activity. In
this study, we have characterized a truncated human m-calpain
that consists of only the protease domain. Unexpectedly, the
proteolytic activity was Ca2+-dependent, very weak, and not
effectively inhibited by calpastatin, a calpain inhibitor. Ca2+-
dependent modification of the protease domain by the cysteine
protease inhibitor, E-64c, was clearly observed as a SDS^PAGE
migration change, indicating that the conformational changes of
this domain are a result of Ca2+ binding. These results suggest
that the Ca2+ binding to domain II, as well as to domains III, IV,
and VI, is critical in the process of complete activation of
calpain. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Calpain (EC 3.4.22.17) is a cytosolic Ca2-dependent cys-
teine protease that regulates cellular substrates by limited pro-
teolysis. Although the physiological functions of calpains are
not completely understood, the existence of calpains in a wide
variety of living organisms, from human to yeast, strongly
suggests their basic and essential functions in intracellular
events, such as signal transduction, cell cycle, di¡erentiation,
and apoptosis [1^4].
Two mammalian calpains, W- and m-calpain, are ubiqui-
tously expressed and have been extensively characterized.
They form a heterodimer comprising an 80-kDa catalytic sub-
unit and a common 30-kDa regulatory subunit. The 3D struc-
ture of m-calpain, in the absence of Ca2, has recently been
determined [5,6]. The 80-kDa and 30-kDa subunits comprise
four (I^IV) and two domains (V and VI), respectively. They
include a papain-like cysteine protease domain (II), a domain
that resembles a Ca2- and phospholipid-binding C2 domain
in 3D structure, but not in primary structure (III) [7], and
Ca2-binding domains containing ¢ve EF-hand motifs (IV
and VI). The W- and m-calpains are activated by distinct
Ca2 concentrations (micromolar and millimolar levels, re-
spectively), followed by autolysis of the N-terminal K-helix
(domain I). The Ca2 concentrations required for the protease
activity are much higher than that in the cytosol, suggesting
that there should be additional factors, such as phospholipids
and activator proteins, to reduce the Ca2 requirement of
calpains [8^12].
The 3D structure of the protease domain has signi¢cant
homology to papain, as predicted from the primary sequence
similarities. One of the most intriguing features in the 3D
structure of m-calpain is that domain II is divided into two
distinct subdomains (IIa and IIb) in the absence of Ca2.
Because of the distance between the two subdomains, the
catalytic triad (Cys105 in domain IIa, and His262 and
Asn286 in domain IIb; numbers of the residues correspond
to the amino acid sequence of human m-calpain 80-kDa sub-
unit (accession number M23254)) is not assembled (see Fig.
4). This composite structure explains the latency of calpain in
the absence of Ca2.
The question arises: is the default structure of domain II of
m-calpain ‘open’ or ‘closed’? From the features described be-
low, we developed a working hypothesis : (1) the default of
domain II is a ‘closed’ conformation, i.e. active, as in the case
of all other papain-like cysteine proteases; (2) the N-terminal
K-helix and domain III force the domain II ‘open’, i.e. inac-
tive, in the absence of Ca2 ; and (3) upon Ca2 binding, the
‘constraint’ of the domain II is cancelled, and the ‘closed’
structure is formed by itself.
The 3D structure of m-calpain suggests that several inter-
domain salt bridges ¢x the domain II structure ‘open’. The N-
terminal K-helix is inserted into the hydrophobic pocket of
domain VI of the 30-kDa subunit and produces salt bridges
between the N-terminal basic residues of the 80-kDa subunit
and acidic residues of domain VI. This interaction should
anchor domain IIa to domain VI. On the other hand, basic
residues in domain IIb interact with acidic residues in domain
III, drawing domain IIb to domain III. Since recent studies
demonstrated that domain III binds Ca2, and that mutations
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in the acidic residue(s) of domain III reduce the Ca2 require-
ment of m-calpain [13,14], it is considered that Ca2 binding
to domain III breaks the salt bridges to domains IIb, resulting
in a ‘closed’ conformation of the protease domain.
Although it has long been believed that domains IV and VI
regulate the protease activity of calpain, the 3D structure of
domain VI in the absence and presence of Ca2 reveals no
remarkable structural change upon Ca2 binding [15,16].
Moreover, both domains are distant from domain II in the
3D structure. These facts strongly suggest that domains IV
and VI are not involved in Ca2-dependent activation of the
calpain molecule.
Based on amino acid sequence similarity and Ca2-binding
experiments, it was predicted that a ‘sixth’ EF-hand motif
existed in the C-terminal region of domain IIb (His319^
Phe331) [17]. The 3D structure of m-calpain reveals that the
region does not form an EF-hand structure and no explicit
Ca2-binding structure was found in any part of domain II
(see Fig. 4 and Section 4).
Thus, it is hypothesized that the default structure of domain
II itself is ‘closed’. To test our working hypothesis, and to
obtain an understanding of the Ca2-dependent activation
mechanism of m-calpain, we produced and characterized a
truncated human m-calpain composed only of domain II.
We predicted that domain II should demonstrate Ca2-inde-
pendent protease activity. Instead, we found an unexpected
property of the domain II: a Ca2-dependent protease activ-
ity.
2. Materials and methods
2.1. Construction of the expression vector
The cDNA fragment corresponding to domain II of human m-
calpain was ampli¢ed by PCR using Pfu polymerase (Stratagene
Inc., CA, USA) and a set of primers, 5P-TGTCAGTTACAGATCTC-
CAGGCGGGAA-3P and 5P-TGGGCTCCCACGAGAGGGCCAT-
CAAGT-3P. The ampli¢ed cDNA was inserted into a NdeI site of
the pET16b vector (Novagen Inc., WI, USA) to produce a truncated
human m-calpain 80-kDa subunit composed of only domain II (res-
idues 19^342) with a N-terminal histidine tag.
2.2. Protein expression
The plasmid constructed was transformed into Escherichia coli
BL21(DE3) (Novagen), and the transformant was cultured at 37‡C
in 1 l of LB medium, containing 100 Wg/ml ampicillin, to an OD of
0.8^1.0 at 600 nm. Protein expression was induced by the presence of
1.0 mM IPTG for 3 h at 30‡C. The harvested cells were suspended in
40 ml of 40 mM imidazole in bu¡er A (20 mM Tris^HCl, pH 7.5, and
300 mM NaCl), and lysed by a French press (American Instrument
Company, MD, USA). The supernatant was recovered by ultracen-
trifugation (35 000Ug, 4‡C, 60 min) and ¢ltered through a 0.22-Wm
pore ¢lter.
The supernatant was then applied to a 7-ml Ni2-chelating agarose
column equilibrated with bu¡er A. The column was washed with 20
mM imidazole in bu¡er A, and eluted with 250 mM imidazole in
bu¡er A. The eluted solution was further puri¢ed by MonoQ
anion-exchange column chromatography with a linear gradient of
0^0.5 M NaCl in 20 mM Tris^HCl (pH 7.5), 5 mM EDTA, and
1 mM dithiothreitol. Puri¢cation was con¢rmed by SDS^PAGE for
its homogeneity. The protein concentration was measured by a Brad-
ford method protein assay kit (Bio-Rad Inc., Yokohama, Japan) ac-
cording to the manufacturer’s instruction. The puri¢ed protein was
stored at 4‡C until use.
2.3. Band mobility shift analysis
Recombinant domain II (0.5 Wg) was incubated for 14 h at 30‡C in
the presence or absence of 5 mM Ca2 with or without 1.6 mM E-64c.
Samples were electrophoresed on SDS^polyacrylamide gels according
to the standard method.
2.4. Caseinolytic assay
Proteolytic activity was measured using casein as a substrate. Re-
combinant domain II (0.5 Wg) was incubated with 3 Wg casein in the
absence or presence of 5 mM Ca2, 1.6 mM E-64c, and/or 1 mg/ml E.
coli-expressed calpastatin domain I (Takara Shuzo, Kyoto, Japan),
one of four functional repetitive units of calpastatin. Reactions were
stopped by adding SDS sample bu¡er (100 mM Tris^HCl, pH 6.8,
20% (v/v) glycerol, 4% (w/v) SDS, 0.4% (w/v) bromophenol blue, and
2% (v/v) 2-mercaptoethanol). Caseinolytic activity was evaluated by
electrophoresis on SDS^polyacrylamide gels with Coomassie brilliant
blue staining.
3. Results
3.1. Expression and puri¢cation of recombinant domain II of
human m-calpain
Domain II (residues 19^342) of the human m-calpain 80-
kDa subunit was expressed in E. coli BL21(DE3) with an N-
terminal histidine tag. The protein was produced in a high
yield, soluble form, and puri¢ed to homogeneity by Ni2-af-
¢nity and MonoQ column chromatography. The elution frac-
tion from the MonoQ column was between 200 and 300 mM
NaCl, which is similar to that of full-length m-calpain. About
12 mg of the protein was puri¢ed from a 2-l culture.
3.2. Recombinant domain II of m-calpain shows
Ca2+-dependent activity
To investigate whether or not the puri¢ed domain II shows
Ca2-independent protease activity, its caseinolytic activity
was examined in the absence or presence of 5 mM Ca2. As
shown in Fig. 1, domain II degraded casein in a Ca2-depen-
dent manner without apparent autolysis. The degradation was
incomplete even after a 14-h incubation (Fig. 1a, lane 7). The
speci¢c activity for caseinolysis was too low to determine pre-
cisely (less than 1/100 of that of full-length m-calpain). Two
Fig. 1. Caseinolytic activity of the domain II. a: Puri¢ed domain II
of human m-calpain was incubated with casein in the presence
(lanes 1^7) or absence (lanes 8^14) of 5 mM Ca2 for 0 (lanes 1
and 8), 0.5 (lanes 2 and 9), 1 (lanes 3 and 10), 2 (lanes 4 and 11), 4
(lanes 5 and 12), 8 (lanes 6 and 13), or 14 h (lanes 7 and 14). Ar-
rowheads and vertical lines indicate the puri¢ed domain II of hu-
man m-calpain and heterogeneous casein molecules, respectively.
b: The time course of casein degradation is shown in the absence
(broken line) or presence (solid line) of 5 mM Ca2. The casein
band intensities were quanti¢ed by densitometry.
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peptidyl £uorescent substrates for W- and m-calpains, succinyl-
Leu-Leu-Val-Tyr-4-methylcoumaryl-7-amide and succinyl-
Leu-Tyr-4-methoxy-2-naphthylamide, were not hydrolyzed
even after a 14-h incubation at 30‡C.
3.3. Ca2+ requirement of recombinant domain II
Since the caseinolytic activity of the domain II increased
almost linearly until 14 h and was maximal at 30‡C, we em-
ployed a 14-h incubation at 30‡C for further analyses. Under
these conditions, the Ca2 dependence of the caseinolytic ac-
tivity of domain II was examined (Fig. 2a). The Ca2 concen-
tration required for the half-maximal activity (Ka) was calcu-
lated to be 0.90 mM, which was even higher than that for full-
length m-calpain (approximately 0.4 mM, [18]; Fig. 2b).
3.4. E¡ect of inhibitors and a mobility shift assay
We examined the e¡ect of calpain inhibitors, E-64c and
calpastatin. E-64c is an active site-directed cysteine protease
inhibitor with a molecular mass of 357.41, and calpastatin is a
ubiquitous protein that inhibits W- and m-calpains e¡ectively
and speci¢cally. As shown in Fig. 3a, domain II was inhibited
completely by E-64c (lane 4), and partially by calpastatin
Fig. 2. Ca2 requirement for the activity of domain II. a: Puri¢ed
domain II was incubated with casein in the absence (lane 1) or pres-
ence of 0.5, 1, 2, 3, 5, or 10 mM Ca2 (lanes 2^7). An arrowhead
and a vertical line indicate the domain II and casein molecules, re-
spectively. b: The casein band intensities in (a) were quanti¢ed by
densitometry.
Fig. 3. E¡ects of E-64c and calpastatin on domain II. a: Caseino-
lytic activity of the domain II was examined by incubation without
inhibitors (lanes 1 and 2), and with E-64c (lanes 3 and 4) or calpas-
tatin domain I (lanes 5 and 6) for 0 (odd lanes) or 14 h (even
lanes). An arrowhead, a vertical line, and an arrow indicate the do-
main II, casein molecules, and calpastatin domain I, respectively.
b: Each sample was run on SDS^polyacrylamide gels after incuba-
tion for 0 (odd lanes) or 14 h (even lanes) in the presence (lanes 1^
4) or absence of Ca2 (lanes 5^8) with (lanes 3, 4, 7, and 8) or
without E-64c (lanes 1, 2, 5, and 6). An arrow indicates the domain
II that showed a change in migration due to modi¢cation by E-64c.
Fig. 4. Ampli¢ed view of an ‘open’ structure of domain II in the
absence of Ca2. The 3D structure of domain II in the absence of
Ca2 is divided into subdomains IIa (cyan, upper side) and IIb
(green, lower side) Catalytic residues (Cys105, His262, and Asn286),
together with acidic residues (Asp96, Glu172, Glu290, Glu320, and
Asp321) possibly involved in ionic repulsion between these subdo-
mains are shown. Yellow, red, blue, and gray balls represent sulfur,
oxygen, nitrogen, and carbon, respectively. A blue tube in domain
IIb indicates the position (residues 319^331) where an EF-hand mo-
tif was once predicted. This ¢gure was prepared using VMD Soft-
ware, version 1.6.1 [21].
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(lane 6). Moreover, calpastatin was partially proteolysed by
domain II.
As shown in Fig. 3b, a clear singlet shift in mobility was
observed only when domain II was incubated in the presence
of Ca2 and E-64c (lane 4), indicating that E-64c was cova-
lently bound to the active site of domain II only in the pres-
ence of Ca2. Thus, it was shown that domain II forms an
active site in a Ca2-dependent manner, and that 100% of the
recombinant domain II was modi¢ed by E-64c. It was possi-
ble, however, that Ca2 was not speci¢c for activation of
domain II, i.e. ionic strength resulted in the activation of
domain II. To eliminate this possibility, we tested the e¡ects
of other ions, including K, Na, Mg2, Mn2, and Ba2 (5
mM each), but these ions did not activate domain II nor cause
a mobility shift (data not shown). Thus, the activation of the
domain II was speci¢c for Ca2.
4. Discussion
In this study, we have puri¢ed and characterized a recombi-
nant domain II of m-calpain, and observed that domain II
showed Ca2-dependent proteolytic activity. Although the
speci¢c activity of domain II was very low, a band shift by
E-64c binding (see Fig. 3b) clearly indicated that all the re-
combinant domain II was correctly folded and active in the
presence of Ca2, and that the low speci¢c activity was not
due to partial denaturation of the protein. Thus, we concluded
that the default state of the domain II is ‘open’, and that it
becomes ‘closed’ upon Ca2 binding.
This raises the question: where is the Ca2-binding site in
the domain II? Andresen et al. showed that only domain II
and its £anking regions of schistosome calpain could bind
Ca2 [17], leading to their speculation that a ‘sixth’ EF-
hand motif in the C-terminal region of domain IIb is a can-
didate for the Ca2-binding site. In the 3D structure of m-
calpain, neither an EF-hand motif nor other Ca2-binding
motifs were found in domain II (Fig. 4). The region (residues
319^331) is highly conserved in various calpain homologs, and
Glu320 and Asp321 in this region and Glu290 in the adjacent
loop are close to Asp96 and Glu172 in domain IIa, indicating
ionic repulsion between domains IIa and IIb (Fig. 4). There-
fore, it is possible that charge neutralization by Ca2 binding
to some of these acidic residues permits closure of domain II.
The low speci¢c activity of domain II suggests that other
domains assist formation of the ‘closed’ active site upon Ca2
binding. Without other domains, domain II may not be able
to form the ‘closed’ structure e⁄ciently. Alternatively, other
domains, especially domain III, may play a role identical to
Ca2 in activating domain II. In other words, domain II may
be able to form the ‘closed’ structure without Ca2 binding to
domain II when the other domains exist. These points may be
clari¢ed by using m-calpain molecules that have mutations in
possible Ca2-binding residues in the domain II. This is now
being examined in our laboratory.
It has been assumed that several ‘atypical’ calpain homo-
logs that lack domains III, IV, and T, such as stomach-speci¢c
nCL-2P [19] and Drosophila SOL [20], might possess Ca2-
independent activity. Our results however, indicate that these
atypical calpains should have Ca2-dependent protease activ-
ity because these acidic residues, comprising a putative Ca2-
binding site, are conserved among these calpain species. On
the other hand, it should be noted that the domain I+II pro-
tein had no proteolytic activity even in the presence of Ca2
(data not shown). Although the possibility that the domain
I+II protein could not fold correctly in E. coli cells cannot be
eliminated, it is possible that the unanchored domain I pre-
vented domain II from forming the ‘closed’ structure.
It was surprising that domain II remained stable and active
for more than 10 h without autolysis (see Fig. 1), compared
with the very rapid inactivation of intact m-calpain (half-life is
less than 1 h). This suggests that inactivation of the intact
calpain is mainly caused by intra/inter-molecular autolytic
degradation dependent upon domains other than the protease
domain. In other words, the domains are important for intra/
inter-molecular autolysis. These points will be clari¢ed by re-
solving the 3D structure of calpain in the presence of Ca2.
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